Evaluating the Efficacy and Safety of TJO-087 in Moderate to Severe Dry Eye Disease Patients
Clinical trial NCT05245604 · UNKNOWN
Trial details
- NCT number
- NCT05245604
- Sponsor
- Taejoon Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-19
- Primary completion
- 2022-08-01
- Enrollment
- 182
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.